87 studies found for:    "Anaplastic ependymoma"
Show Display Options
Rank Status Study
21 Completed Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
Conditions: Adult Anaplastic Astrocytoma;   Adult Anaplastic Ependymoma;   Adult Anaplastic Oligodendroglioma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Mixed Glioma;   Recurrent Adult Brain Tumor;   Tumors Metastatic to Brain;   Adult Anaplastic Oligoastrocytoma
Interventions: Drug: bafetinib;   Procedure: microdialysis;   Other: pharmacological study;   Other: liquid chromatography;   Other: mass spectrometry;   Other: laboratory biomarker analysis;   Genetic: protein expression analysis;   Genetic: western blotting;   Other: immunohistochemistry staining method;   Procedure: therapeutic conventional surgery
22 Recruiting 3T MRI Biomarkers of Glioma Treatment Response
Conditions: Adult Anaplastic Astrocytoma;   Adult Anaplastic Ependymoma;   Adult Anaplastic Oligodendroglioma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Recurrent Adult Brain Tumor
Interventions: Device: 3-Tesla magnetic resonance imaging;   Device: CEST-MRI;   Device: DW-MRI;   Device: DCE-MRI;   Device: DSC-MRI;   Drug: IV administration of gadolinium-containing contrast agent
23 Terminated Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors
Conditions: Adult Anaplastic Astrocytoma;   Adult Anaplastic Ependymoma;   Adult Anaplastic Oligodendroglioma;   Adult Brain Stem Glioma;   Adult Central Nervous System Germ Cell Tumor;   Adult Choroid Plexus Tumor;   Adult Craniopharyngioma;   Adult Diffuse Astrocytoma;   Adult Ependymoblastoma;   Adult Ependymoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Grade I Meningioma;   Adult Grade II Meningioma;   Adult Grade III Meningioma;   Adult Medulloblastoma;   Adult Meningeal Hemangiopericytoma;   Adult Mixed Glioma;   Adult Myxopapillary Ependymoma;   Adult Oligodendroglioma;   Adult Pilocytic Astrocytoma;   Adult Pineoblastoma;   Adult Pineocytoma;   Adult Subependymoma;   Adult Supratentorial Primitive Neuroectodermal Tumor (PNET);   Meningeal Melanocytoma
Interventions: Drug: EF5;   Procedure: conventional surgery;   Procedure: positron emission tomography;   Radiation: fluorine F 18 EF5;   Other: pharmacological study
24 Active, not recruiting Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
Conditions: Adult Anaplastic Astrocytoma;   Adult Anaplastic Ependymoma;   Adult Anaplastic Oligodendroglioma;   Adult Brain Stem Glioma;   Adult Diffuse Astrocytoma;   Adult Ependymoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Mixed Glioma;   Adult Myxopapillary Ependymoma;   Adult Oligodendroglioma;   Adult Pilocytic Astrocytoma;   Adult Pineal Gland Astrocytoma;   Adult Subependymal Giant Cell Astrocytoma;   Adult Subependymoma
Interventions: Procedure: biopsy;   Procedure: computed tomography;   Procedure: therapeutic conventional surgery;   Radiation: radiation therapy treatment planning/simulation;   Radiation: radiation therapy;   Procedure: magnetic resonance imaging;   Procedure: positron emission tomography;   Drug: fluorine F 18 fluorodopa
25 Recruiting Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors
Conditions: Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Ependymoma;   Recurrent Childhood Diffuse Astrocytoma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliosarcoma;   Recurrent Childhood Oligodendroglioma;   Recurrent Childhood Brain Stem Glioma
Interventions: Drug: imetelstat sodium;   Other: laboratory biomarker analysis;   Other: pharmacological study
26 Not yet recruiting Study of Everolimus (RAD001, Afinitor®) for Children With Recurrent or Progressive Ependymoma
Condition: Recurrent Childhood Ependymoma
Intervention: Drug: Everolimus
27 Completed Fatigue, Sleep and Cytokines in Primary Brain Tumor (PBT) Patients
Condition: Brain Cancer
Intervention: Behavioral: Questionnaire
28 Active, not recruiting Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma
Conditions: Brain Tumors;   Spinal Cord Tumors
Interventions: Drug: Temozolomide;   Drug: Lapatinib
29 Completed Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: therapeutic autologous lymphocytes;   Genetic: gene expression analysis;   Other: laboratory biomarker analysis
30 Completed Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders
Conditions: Brain and Central Nervous System Tumors;   Metastatic Cancer;   Radiation Toxicity
Intervention: Other: Questionnaire
31 Completed Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: hydroxyurea;   Drug: imatinib mesylate;   Drug: vatalanib
32 Completed Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Procedure: conventional surgery;   Radiation: iodine I 131 monoclonal antibody 81C6;   Radiation: radiation therapy
33 Completed Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas
Conditions: Brain and Central Nervous System Tumors;   Breast Cancer;   Kidney Cancer;   Lung Cancer;   Lymphoma;   Melanoma (Skin);   Ovarian Cancer;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: carboxyamidotriazole;   Drug: paclitaxel
34 Completed Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: imatinib mesylate;   Other: pharmacological study;   Procedure: conventional surgery
35 Completed Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas
Condition: Brain and Central Nervous System Tumors
Intervention: Radiation: iodine I 131 monoclonal antibody 81C6
36 Unknown  Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy
Conditions: Brain and Central Nervous System Tumors;   Thrombocytopenia
Interventions: Drug: temozolomide;   Genetic: comparative genomic hybridization;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Radiation: radiation therapy
37 Completed Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
Conditions: Brain and Central Nervous System Tumors;   Breast Cancer;   Gastrointestinal Carcinoid Tumor;   Islet Cell Tumor;   Lung Cancer;   Lymphoma;   Melanoma (Skin);   Neoplastic Syndrome
Intervention: Radiation: yttrium Y 90-edotreotide
38 Withdrawn Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Procedure: conventional surgery;   Procedure: magnetic resonance imaging;   Procedure: magnetic resonance spectroscopic imaging
39 Terminated Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Conditions: Brain and Central Nervous System Tumors;   Lymphoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: filgrastim;   Biological: sargramostim;   Biological: therapeutic autologous lymphocytes;   Drug: O6-benzylguanine;   Drug: carmustine;   Drug: temozolomide;   Procedure: in vitro-treated peripheral blood stem cell transplantation
40 Withdrawn Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Other: laboratory biomarker analysis;   Procedure: biopsy;   Procedure: magnetic resonance imaging;   Radiation: gadopentetate dimeglumine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years